HEALTH● LOWOct 2 · Oct 2, 2026, 8:20 PM
Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma
Seeking Alpha Tech · global
Eli Lilly's drug, Jaypirca, has received an expanded indication for the treatment of previously untreated leukemia and lymphoma. This represents an advancement in cancer therapy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH24m agoTrump’s CDC sending disease detective to Pennsylvania to help fight worst measles outbreak in 35 yearsThe Independent WorldHEALTH34m agoGood news for Parkinson's patients: a key remedy will be available again in NovemberClarínHEALTH1h agoA tooth grew in a teenager's eye and doctors removed it with surgery: the case that amazed world medicineClarínHEALTH1h agoFG releases ₦40.7 billion for primary healthcare, expands coverage to 13,000 facilitiesPremium Times